01-06-2017 | Erratum
Erratum to: Dose–response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study
Published in: Clinical and Experimental Nephrology | Issue 3/2017
Login to get access